Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.51 |
| ▸ | LMNA | P02545 | 6/20 | 0.51 |
| ▸ | HTT | P42858 | 4/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3528049 | 0.83 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2LMNAHTTNPSR1 | |
| SCHEMBL2279251 | 0.82 | KDM4E (0.62) | ALDH1A1SMN1; SMN2LMNAHTTNPSR1 | |
| SCHEMBL21543996 | 0.82 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2LMNAHTTNPSR1 | |
| SCHEMBL15782798 | 0.79 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2LMNAHTTNPSR1 | |
| SCHEMBL679558 | 0.76 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2LMNAHTTNPSR1 | |
| SCHEMBL7379657 | 0.75 | CYP1A2 (0.45) | ALDH1A1SMN1; SMN2LMNAMAPTGAA | |
| SCHEMBL3188766 | 0.75 | CYP1A2 (0.45) | ALDH1A1SMN1; SMN2MAPTGAAKDM4E | |
| SCHEMBL24079174 | 0.72 | KDM4E (0.54) | ALDH1A1SMN1; SMN2LMNAHTTNPSR1 | |
| SCHEMBL3728873 | 0.71 | CYP1A2 (0.40) | ALDH1A1SMN1; SMN2LMNAHTTNPSR1 | |
| SCHEMBL2551804 | 0.71 | MAPK1 (0.50) | ALDH1A1SMN1; SMN2LMNAHTTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4172153-A1 | SUBSTITUTED HETEROARYLOXYPYRIDINES, THE SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS | Bayer Aktiengesellschaft (DE) | 2023-05-03 | — | — | EP | disclosed |
| CN-115996919-A | Substituted heteroaryloxy pyridines, salts thereof and their use as herbicides | 拜耳公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-1538145-B1 | PROCESS FOR PRODUCTION OF PHENOXY-SUBSTITUTED 2-PYRIDONE COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2016-02-17 | — | — | EP | disclosed |
| US-20090143368-A1 | Use of Cinnamoyl Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-06-04 | — | — | US | disclosed |
| EP-1857104-A1 | USE OF CINNAMOYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-11-21 | — | — | EP | disclosed |
| US-7189855-B2 | Process for production of phenoxy-substituted 2-pyridone compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-03-13 | — | — | US | disclosed |
| US-7189855-B2 | Process for production of phenoxy-substituted 2-pyridone compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-03-13 | — | — | US | disclosed |
| US-7189855-B2 | Process for production of phenoxy-substituted 2-pyridone compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-03-13 | — | — | US | disclosed |
| US-20050154210-A1 | Process for production of phenoxy-substituted 2-pyridone compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1538145-A1 | PROCESS FOR PRODUCTION OF PHENOXY-SUBSTITUTED 2-PYRIDONE COMPOUNDS | Sumitomo Chemical Company, Limited (JP) | 2005-06-08 | — | — | EP | disclosed |
| US-4559347-A | 3-Substituted-5-alkyl-1,6-naphthyridin-2(1H)-ones, cardiotonic use and preparation thereof | STERLING DRUG INC. (US) | 1985-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154210-A1 | Process for production of phenoxy-substituted 2-pyridone compounds | PDK2, ME1, PDXK | ALDH1A1 57/4885SMN1; SMN2 4015/4885LMNA 2778/4885 |
| US-20090143368-A1 | Use of Cinnamoyl Compound | COL2A1, COL1A1, SMAD2 | ALDH1A1 749/4885SMN1; SMN2 4490/4885LMNA 1153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.